Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
GEHC 
GE HealthCare Technologies Inc. (GEHC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/09/2025: GEHC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
21 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $88.76
1 Year Target Price $88.76
| 12 | Strong Buy |
| 4 | Buy |
| 5 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -3.19% | Avg. Invested days 31 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/09/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 37.94B USD | Price to earnings Ratio 17.2 | 1Y Target Price 88.76 |
Price to earnings Ratio 17.2 | 1Y Target Price 88.76 | ||
Volume (30-day avg) 21 | Beta 1.24 | 52 Weeks Range 57.57 - 94.66 | Updated Date 12/9/2025 |
52 Weeks Range 57.57 - 94.66 | Updated Date 12/9/2025 | ||
Dividends yield (FY) 0.16% | Basic EPS (TTM) 4.83 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 10.95% | Operating Margin (TTM) 14.21% |
Management Effectiveness
Return on Assets (TTM) 5.46% | Return on Equity (TTM) 24.45% |
Valuation
Trailing PE 17.2 | Forward PE 16.69 | Enterprise Value 45667875252 | Price to Sales(TTM) 1.87 |
Enterprise Value 45667875252 | Price to Sales(TTM) 1.87 | ||
Enterprise Value to Revenue 2.26 | Enterprise Value to EBITDA 12.02 | Shares Outstanding 455521592 | Shares Floating 454068478 |
Shares Outstanding 455521592 | Shares Floating 454068478 | ||
Percent Insiders 0.27 | Percent Institutions 89.22 |
Upturn AI SWOT
GE HealthCare Technologies Inc.
Company Overview
History and Background
GE HealthCare Technologies Inc. (GEHC) was spun off from General Electric Company on January 4, 2023. Prior to the spin-off, it operated as a segment of GE. The company has a long history dating back to the early days of medical imaging, with significant innovations in X-ray, CT, MRI, and ultrasound technologies. Its evolution is marked by continuous investment in research and development, strategic acquisitions, and the integration of digital technologies into its offerings.
Core Business Areas
- Description: This segment is a leading provider of diagnostic imaging equipment and solutions, including MRI, CT, X-ray, and molecular imaging systems. It also offers related consumables and software.
- Segment Name: Imaging
- Description: GE HealthCare is a major player in the ultrasound market, offering a wide range of ultrasound systems for various clinical applications, from general imaging to cardiac and fetal diagnostics. It also provides ultrasound probes and software.
- Segment Name: Ultrasound
- Description: This segment encompasses a portfolio of products and services designed to enhance patient care and workflow efficiency. It includes anesthesia delivery, respiratory care, patient monitoring, and enterprise imaging solutions.
- Segment Name: Applied Solutions
- Description: This segment focuses on providing contrast media and radiopharmaceuticals used in medical imaging procedures to enhance visualization of internal body structures.
- Segment Name: Pharmaceutical Diagnostics
Leadership and Structure
GE HealthCare Technologies Inc. is led by a dedicated executive leadership team, with Peter J. Arduini serving as President and Chief Executive Officer. The company is structured around its core business segments, with specialized leadership for each division. Its board of directors oversees the strategic direction and governance of the company.
Top Products and Market Share
Key Offerings
- Competitors: Siemens Healthineers,Philips Healthcare,Canon Medical Systems
- Description: GE HealthCare's Revolution CT scanners are advanced computed tomography systems known for their speed, image quality, and dose reduction capabilities. These are critical for diagnosing a wide range of conditions. Competitors include Siemens Healthineers, Philips Healthcare, and Canon Medical Systems. Specific market share data for individual product lines is proprietary, but GEHC is a top-tier player in the CT market.
- Product Name: Revolution CT Scanners
- Competitors: Philips Healthcare,Siemens Healthineers,Fujifilm SonoSite
- Description: The LOGIQ series represents GE HealthCare's versatile ultrasound platforms, catering to various clinical needs, including abdominal, obstetric, and cardiac imaging. They are recognized for their image clarity and user-friendly interface. Key competitors include Philips Healthcare, Siemens Healthineers, and Fujifilm SonoSite. GEHC holds a significant share in the global ultrasound market.
- Product Name: LOGIQ Ultrasound Systems
- Competitors: Siemens Healthineers,Philips Healthcare,Canon Medical Systems
- Description: GE HealthCare's Signa MRI systems are high-performance magnetic resonance imaging devices offering advanced imaging techniques for neurological, musculoskeletal, and cardiovascular applications. They aim to improve diagnostic accuracy and patient comfort. Major competitors include Siemens Healthineers, Philips Healthcare, and Canon Medical Systems. GEHC is a leading provider in the MRI market.
- Product Name: Signa MR Systems
- Competitors: Bayer AG,Bracco Imaging
- Description: This range of contrast agents is crucial for enhancing the visibility of organs and tissues in CT and MRI scans. These are essential consumables for diagnostic imaging. Key competitors include Bayer AG and Bracco Imaging. This is a highly competitive market with established players.
- Product Name: Omni Contrast Agents
Market Dynamics
Industry Overview
The global medical technology industry is characterized by continuous innovation, increasing demand for advanced diagnostics and treatments, and a growing emphasis on value-based healthcare. Key trends include the integration of artificial intelligence and digital solutions, the need for cost-effectiveness, and an aging global population driving demand for healthcare services. The industry is highly regulated and competitive.
Positioning
GE HealthCare Technologies Inc. is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator. Its competitive advantages include a broad product portfolio, strong brand recognition, a global sales and service network, and a legacy of innovation. The company is well-positioned to capitalize on trends such as personalized medicine, remote patient monitoring, and the growing demand for efficient diagnostic solutions.
Total Addressable Market (TAM)
The total addressable market for medical imaging and diagnostic equipment is substantial and projected to grow significantly. While precise TAM figures vary by segment and reporting agency, it is estimated to be in the hundreds of billions of dollars globally. GE HealthCare Technologies Inc. is a major player across several key segments of this TAM, particularly in MRI, CT, and Ultrasound, and aims to expand its digital offerings to capture a larger share of the evolving market.
Upturn SWOT Analysis
Strengths
- Strong brand reputation and long-standing presence in the healthcare industry.
- Comprehensive portfolio of imaging and diagnostic solutions.
- Extensive global sales, service, and distribution network.
- Significant investment in research and development (R&D) for innovation.
- Expertise in digital health solutions and AI integration.
Weaknesses
- Reliance on capital equipment sales, which can be cyclical.
- Integration challenges from past parent company structure and potential future acquisitions.
- Competition from agile and specialized medical technology companies.
- Potential impact of supply chain disruptions on manufacturing and delivery.
Opportunities
- Growth in emerging markets with increasing healthcare access.
- Expansion of AI-driven diagnostic tools and digital health platforms.
- Increasing demand for minimally invasive diagnostic procedures.
- Strategic partnerships and acquisitions to enhance product offerings and market reach.
- Focus on personalized medicine and precision diagnostics.
Threats
- Intense competition from established and new market entrants.
- Increasing price pressures and reimbursement challenges from healthcare providers and payers.
- Rapid technological advancements requiring continuous adaptation.
- Regulatory changes and compliance hurdles in different regions.
- Global economic downturns impacting healthcare spending.
Competitors and Market Share
Key Competitors
- Siemens Healthineers (Germany)
- Philips Healthcare (Netherlands)
- Canon Medical Systems (Japan)
- Hitachi Medical Corporation (Japan)
- FUJIFILM Holdings Corporation (Japan)
Competitive Landscape
GE HealthCare Technologies Inc. operates in a highly competitive landscape. Its advantages lie in its broad product offering, established customer relationships, and robust R&D capabilities. However, competitors like Siemens Healthineers and Philips Healthcare are also strong innovators with significant global reach and diverse portfolios. The industry is characterized by rapid technological advancements, and companies must continuously invest in innovation to maintain their competitive edge. Price, technological innovation, regulatory compliance, and service quality are key differentiating factors.
Growth Trajectory and Initiatives
Historical Growth: GE HealthCare Technologies Inc., drawing on its long history within General Electric, has a track record of steady growth in the medical technology sector. Its historical growth has been fueled by innovation in imaging technologies, expansion into new markets, and strategic acquisitions. Post-spin-off, the company is focused on accelerating this growth trajectory as an independent entity.
Future Projections: Analyst projections for GE HealthCare Technologies Inc. generally indicate continued revenue growth, driven by increasing demand for diagnostic imaging, advancements in AI and digital health, and expansion in emerging markets. The company's focus on key growth areas like personalized medicine and integrated care solutions is expected to underpin future financial performance. Specific growth rate projections vary among analysts and are subject to market conditions.
Recent Initiatives: Recent initiatives by GE HealthCare Technologies Inc. include a strong focus on digital transformation, integrating AI into its imaging and data analytics platforms, and expanding its portfolio of at-home and remote care solutions. The company is also emphasizing sustainability in its operations and product development. Strategic partnerships and potential bolt-on acquisitions are also part of its growth strategy.
Summary
GE HealthCare Technologies Inc. is a strong player in the global medical technology market, leveraging its broad product portfolio and established reputation. Its core imaging and diagnostic solutions, coupled with a growing focus on digital health and AI, position it well for future growth. While facing intense competition and market pressures, the company's strategic initiatives and commitment to innovation are key to maintaining its market leadership and delivering shareholder value.
Similar Stocks
Sources and Disclaimers
Data Sources:
- GE HealthCare Technologies Inc. Investor Relations
- Securities and Exchange Commission (SEC) Filings
- Industry Market Research Reports
- Financial News and Analysis Websites
Disclaimers:
This information is for informational purposes only and does not constitute financial advice. Market share data is estimated and may vary based on reporting methodology and the specific segment analyzed. Future projections are based on analyst estimates and are subject to change. Investing in the stock market involves risks, and investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About GE HealthCare Technologies Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 2023-01-04 | President, CEO & Director Mr. Peter J. Arduini | ||
Sector Healthcare | Industry Health Information Services | Full time employees 53000 | Website https://www.gehealthcare.com |
Full time employees 53000 | Website https://www.gehealthcare.com | ||
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.